Literature DB >> 31846618

The role of liposomes in clinical nanomedicine development. What now? Now what?

Daan J A Crommelin1, Peter van Hoogevest2, Gert Storm3.   

Abstract

The rapid rise in interest in 'nanomedicines' in the academic world over the last twenty years and the claims of success led to calls for reflection. The main body of text of this Commentary will be on answering the question: 'where to go with nanomedicines'? Research priorities for the future will be outlined based on experience with the most successful nanomedicines family within the broad field of nanomedicine so far: liposomes. An analysis of currently clinically tested, approved and marketed liposome-drug combinations provides these insights.
Copyright © 2019 Elsevier B.V. All rights reserved.

Keywords:  Clinical trials; Liposomes; Nanomedicines

Mesh:

Substances:

Year:  2019        PMID: 31846618     DOI: 10.1016/j.jconrel.2019.12.023

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  38 in total

1.  Design, fabrication and applications of tetrahedral DNA nanostructure-based multifunctional complexes in drug delivery and biomedical treatment.

Authors:  Tao Zhang; Taoran Tian; Ronghui Zhou; Songhang Li; Wenjuan Ma; Yuxin Zhang; Nanxin Liu; Sirong Shi; Qianshun Li; Xueping Xie; Yichen Ge; Mengting Liu; Qi Zhang; Shiyu Lin; Xiaoxiao Cai; Yunfeng Lin
Journal:  Nat Protoc       Date:  2020-07-15       Impact factor: 13.491

2.  Endogenous Oleoylethanolamide Crystals Loaded Lipid Nanoparticles with Enhanced Hydrophobic Drug Loading Capacity for Efficient Stroke Therapy.

Authors:  Shichao Wu; Di Liao; Xi Li; Zeyu Liu; Lin Zhang; Fong Ming Mo; Shuo Hu; Jian Xia; Xiangrui Yang
Journal:  Int J Nanomedicine       Date:  2021-12-21

3.  Reactive Oxygen Species (ROS) Activated Liposomal Cell Delivery using a Boronate-Caged Guanidine Lipid.

Authors:  Jinchao Lou; Megan L Qualls; Macy M Hudson; Dillon P McBee; Joshua A Baccile; Michael D Best
Journal:  Chemistry       Date:  2022-06-27       Impact factor: 5.020

4.  Platelet-mimicking procoagulant nanoparticles augment hemostasis in animal models of bleeding.

Authors:  Ujjal Didar Singh Sekhon; Kelsey Swingle; Aditya Girish; Norman Luc; Maria de la Fuente; Jurgis Alvikas; Shannon Haldeman; Adnan Hassoune; Kaisal Shah; Youjoung Kim; Steven Eppell; Jeffrey Capadona; Andrew Shoffstall; Matthew D Neal; Wei Li; Marvin Nieman; Anirban Sen Gupta
Journal:  Sci Transl Med       Date:  2022-01-26       Impact factor: 19.319

Review 5.  Challenges and opportunities in metastatic breast cancer treatments: Nano-drug combinations delivered preferentially to metastatic cells may enhance therapeutic response.

Authors:  Jesse Yu; Qingxin Mu; Millie Fung; Xiaolin Xu; Linxi Zhu; Rodney J Y Ho
Journal:  Pharmacol Ther       Date:  2022-01-06       Impact factor: 13.400

6.  Synergistic Antitumor Efficacy Mediated by Liposomal Co-Delivery of Polymeric Micelles of Vinorelbine and Cisplatin in Non-Small Cell Lung Cancer.

Authors:  Shuhang Wang; Jingxin Gou; Yue Wang; Xinyi Tan; Linxuan Zhao; Xiangqun Jin; Xing Tang
Journal:  Int J Nanomedicine       Date:  2021-03-22

Review 7.  Cationic Nanoparticle-Based Cancer Vaccines.

Authors:  Jeroen Heuts; Wim Jiskoot; Ferry Ossendorp; Koen van der Maaden
Journal:  Pharmaceutics       Date:  2021-04-21       Impact factor: 6.321

Review 8.  Nanomedicines in the treatment of colon cancer: a focus on metallodrugs.

Authors:  Pedro Farinha; Jacinta O Pinho; Mariana Matias; M Manuela Gaspar
Journal:  Drug Deliv Transl Res       Date:  2021-02-22       Impact factor: 4.617

Review 9.  Peptide-Enabled Targeted Delivery Systems for Therapeutic Applications.

Authors:  Mingpeng Liu; Xiaocui Fang; Yanlian Yang; Chen Wang
Journal:  Front Bioeng Biotechnol       Date:  2021-07-01

Review 10.  Recent Advances in Stimulus-Responsive Nanocarriers for Gene Therapy.

Authors:  Cheng Yu; Long Li; Pei Hu; Yan Yang; Wei Wei; Xin Deng; Lu Wang; Franklin R Tay; Jingzhi Ma
Journal:  Adv Sci (Weinh)       Date:  2021-05-16       Impact factor: 16.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.